AbCellera Biologics Inc.
ABCL • NASDAQ • Stock Fundamentals
AbCellera Biologics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carl Hansen, with a market cap of $1.6B.
Market Cap$1.6B
Employees586.0
CEOCarl Hansen
CountryCanada
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
AbCellera Biologics Inc. FAQ
Common questions about AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) has a market capitalization of $1.6B and trades on NASDAQ.
AbCellera Biologics Inc. has approximately 586 employees.